Tumour size is the only predictive factor of distant recurrence after pathological complete response to neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancers: a sub-study of EORTC 10994/BIG 1-00 phase III trial

Nom du journal : Eur J Cancer

Année : 2015

Volume : 51

Page de départ : 301

Page de fin : 309

Auteurs: Fei F, Messina C, Slaets L, Chakiba C, Cameron D, Bogaerts J, Bonnefoi H, Messina C,